Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NIH 11OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 880Neoplasms 696Prostatic Neoplasms 468Lung Neoplasms 383Carcinoma, Non-Small-Cell Lung 351Colorectal Neoplasms 329Leukemia, Myeloid, Acute 278Pancreatic Neoplasms 223Neoplasm Metastasis 219Brain Neoplasms 214Multiple Myeloma 207Carcinoma, Hepatocellular 195Head and Neck Neoplasms 181Precursor Cell Lymphoblastic Leukemia-Lymphoma 163Ovarian Neoplasms 163Glioblastoma 163Melanoma 162Squamous Cell Carcinoma of Head and Neck 159Rectal Neoplasms 137Recurrence 135Hematologic Neoplasms 131Uterine Cervical Neoplasms 130Sarcoma 128Stomach Neoplasms 124Triple Negative Breast Neoplasms 123Glioma 119Carcinoma, Renal Cell 118Urinary Bladder Neoplasms 112Colonic Neoplasms 109Myelodysplastic Syndromes 106

Interventions

talazoparib 1irinotecan sucrosofate 1Temozolomide 1Liquid Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Neuroectodermal Tumors, Primitive, Peripheral × 90 days × Clear all
NCT04901702 2026-05-19

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
90 enrolled
CNSGastrointestinalGenitourinarySarcoma

Neoplasms, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor

NCT06068075 2026-05-05

Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD

Dana-Farber Cancer Institute

Phase NA Active not recruiting
340 enrolled
Sarcoma

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡